CommercialCoverageMedium impact
11.17.06w, Surgical and Minimally Invasive Treatments for Urinary Outlet Obstruction due to Benign Prostatic Hyperplasia (BPH)
Independence Blue Cross·Urology·Medical Policy
Effective date
Jan 1, 2026
We identified it
Jun 19, 2026
Summary
Policy 11.17.06w establishes coverage guidelines for surgical and minimally invasive treatments for urinary outlet obstruction due to benign prostatic hyperplasia (BPH), effective January 1, 2026. This new policy will define which BPH treatment procedures are covered, any prior authorization requirements, and medical necessity criteria that billing and clinical teams must follow.
Action Required
By December 31, 2025: Billing and clinical teams must obtain and review the complete Policy 11.17.06w text to identify: (1) covered vs. non-covered BPH surgical and minimally invasive procedures; (2) prior authorization requirements; (3) medical necessity criteria; (4) specific CPT/HCPCS codes affected. Update billing software with any new authorization rules, payer edits, or code restrictions. Educate providers and front-desk staff on documentation requirements and authorization workflows. Notify urology providers of any changes to their standard BPH treatment coding or reimbursement. Contact the payer (IBX) if the full policy text is not accessible via the provided URL to ensure compliance before January 1, 2026.